Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Controlled Release Drug Delivery Market, by Release Mechanism
1.4.2 North America Controlled Release Drug Delivery Market, by Technology
1.4.3 North America Controlled Release Drug Delivery Market, by Application
1.4.4 North America Controlled Release Drug Delivery Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. Strategies Deployed in Controlled Release Drug Delivery Market
Chapter 5. North America Controlled Release Drug Delivery Market by Release Mechanism
5.1 North America Feedback Regulated Drug Delivery Systems Market by Country
5.2 North America Activation-modulated Drug Delivery Systems Market by Country
5.3 North America Chemically Activated Market by Country
5.4 North America Polymer Based Systems Market by Country
5.5 North America Micro Reservoir Partition Controlled Drug Delivery Systems Market by Country
Chapter 6. North America Controlled Release Drug Delivery Market by Technology
6.1 North America Targeted Delivery Market by Country
6.2 North America Coacervation Market by Country
6.3 North America Micro Encapsulation Market by Country
6.4 North America Transdermal Market by Country
6.5 North America Implants Market by Country
6.6 North America Wurster Technique Market by Country
6.7 North America Others Market by Country
Chapter 7. North America Controlled Release Drug Delivery Market by Application
7.1 North America Oral Controlled-drug delivery Systems Market by Country
7.2 North America Metered Dose Inhalers Market by Country
7.3 North America Injectable Market by Country
7.4 North America Transdermal & Ocular Patches Market by Country
7.5 North America Infusion Pumps & Drug Eluting Stents Market by Country
Chapter 8. North America Controlled Release Drug Delivery Market by Country
8.1 US Controlled Release Drug Delivery Market
8.1.1 US Controlled Release Drug Delivery Market by Release Mechanism
8.1.2 US Controlled Release Drug Delivery Market by Technology
8.1.3 US Controlled Release Drug Delivery Market by Application
8.2 Canada Controlled Release Drug Delivery Market
8.2.1 Canada Controlled Release Drug Delivery Market by Release Mechanism
8.2.2 Canada Controlled Release Drug Delivery Market by Technology
8.2.3 Canada Controlled Release Drug Delivery Market by Application
8.3 Mexico Controlled Release Drug Delivery Market
8.3.1 Mexico Controlled Release Drug Delivery Market by Release Mechanism
8.3.2 Mexico Controlled Release Drug Delivery Market by Technology
8.3.3 Mexico Controlled Release Drug Delivery Market by Application
8.4 Rest of North America Controlled Release Drug Delivery Market
8.4.1 Rest of North America Controlled Release Drug Delivery Market by Release Mechanism
8.4.2 Rest of North America Controlled Release Drug Delivery Market by Technology
8.4.3 Rest of North America Controlled Release Drug Delivery Market by Application
Chapter 9. Company Profiles
9.1 Johnson & Johnson
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental & Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 Merck & Co., Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Geographical Expansions:
9.2.6 SWOT Analysis
9.3 Alkermes PLC
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 SWOT Analysis
9.4 Pfizer, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional & Segmental Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Geographical Expansions:
9.4.6 SWOT Analysis
9.5 Assertio Holdings, Inc. (Assertio Therapeutics, Inc.)
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Recent strategies and developments:
9.5.3.1 Acquisition and Mergers:
9.5.4 SWOT Analysis
9.6 Lonza Group Ltd. (Capsugel)
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expenses
9.6.5 Recent strategies and developments:
9.6.5.1 Product Launches and Product Expansions:
9.6.6 SWOT Analysis
9.7 Colorcon, Inc. (BPSI Holdings LLC.)
9.7.1 Company Overview
9.7.2 Recent strategies and developments:
9.7.2.1 Product Launches and Product Expansions:
9.7.2.2 Acquisition and Mergers:
9.7.2.3 Geographical Expansions:
9.7.3 SWOT Analysis
9.8 Corium, LLC (Gurnet Point Capital)
9.8.1 Company Overview
9.8.2 Recent strategies and developments:
9.8.2.1 Product Launches and Product Expansions:
9.8.3 SWOT Analysis
9.9 Adare Pharma Solutions
9.9.1 Company Overview
9.9.2 Recent strategies and developments:
9.9.2.1 Acquisition and Mergers:
9.9.3 SWOT Analysis
9.10. Coating Place, Inc.
9.10.1 Company Overview
9.10.2 SWOT Analysis
Unique Offerings 